VivoSim Labs, INC. (VIVS) › Cash & EquivalentsVivoSim Labs, INC. (VIVS) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $141.0K2010: $285.0K2011: $340.0K2012: $14.82M2013: $15.63M2014: $48.17M2015: $50.14M2016: $62.09M2017: $62.75M2018: $43.73M2019: $36.48M2020: $27.36M2021: $37.36M2022: $28.68M2023: $15.30M2024: $2.90M2025: $11.31M2026: $5.02M$5.02M2009Cash & Equivalents (USD)2026Fiscal YearCash & EquivalentsChange YoY2026$5.02M-55.6%2025$11.31M+289.9%2024$2.90M-81.0%2023$15.30M-46.6%2022$28.68M-23.3%2021$37.36M+36.6%2020$27.36M-25.0%2019$36.48M-16.6%2018$43.73M-30.3%2017$62.75M+1.1%2016$62.09M+23.8%2015$50.14M+4.1%2014$48.17M+208.2%2013$15.63M+5.5%2012$14.82M+4257.9%2011$340.0K+19.3%2010$285.0K+102.1%2009$141.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share